H-group (homology)
304.45 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase, HPPK
Ligands and drugs
201
Member domains
127
with ligand contacts (≤ 4 Å)
63.2% of members
123
with DrugDomain annotations
61.2% of members
98
with a DrugBank compound
48.8% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 304.45 belongs to X-group 304 Alpha-beta plaits, which binds 8.8 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 52 |
| DB00171 | ATP | ATP | 18 |
| DB02119 | PH2 | 6-Hydroxymethyl-7,8-Dihydropterin | 15 |
| DB00131 | AMP | Adenosine phosphate | 12 |
| DB03197 | HHR | 6-Hydroxymethylpterin | 4 |
| DB02278 | ROI | 7,8-dihydro-7,7-dimethyl-6-hydroxypterin | 2 |
| DB04047 | HH2 | 6-hydroxymethylpterin diphosphate | 2 |
| DB00352 | DX4 | Tioguanine | 1 |
| DB03592 | PMM | Pterin-6-Yl-Methyl-Monophosphate | 1 |
| DB04158 | A4P | 6-(adenosine tetraphosphate-methyl)-7,8-dihydropterin | 1 |
| DB04610 | 87Y | 7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin | 1 |
| DB16833 | ADP | Adenosine disphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 76 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 52 |
| CL | CHLORIDE ION | 42 |
| CAmetal | CALCIUM ION | 39 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 18 |
| PH2 | 2-AMINO-6-HYDROXYMETHYL-7,8-DIHYDRO-3H-PTERIDIN-4-ONE | 17 |
| AMP | ADENOSINE MONOPHOSPHATE | 12 |
| NAmetal | SODIUM ION | 12 |
| PE0 | PTERINE | 5 |
| 5RV | 2-[(2-azanyl-6-oxidanylidene-3,9-dihydropurin-8-yl)sulfanylmethyl]benzenecarbonitrile | 4 |
| H73 | 5'-S-[(2R,4R)-1-{2-[(2-amino-7,7-dimethyl-4-oxo-3,4,7,8-tetrahydropteridine-6-carbonyl)amino]ethyl}-2-carboxypiperidin-4-yl]-5'-thioadenosine | 4 |
| HHR | 6-HYDROXYMETHYLPTERIN | 4 |
| 5RW | 2-azanyl-8-[(4-fluorophenyl)methylsulfanyl]-1,7-dihydropurin-6-one | 3 |
| 5RX | 2-azanyl-8-[(4-chlorophenyl)methylsulfanyl]-1,9-dihydropurin-6-one | 3 |
| 5RY | 4-[(2-azanyl-6-oxidanylidene-1,9-dihydropurin-8-yl)sulfanylmethyl]-3-fluoranyl-benzenecarbonitrile | 3 |
| YH2 | 4-{[(2-amino-6-oxo-6,9-dihydro-1H-purin-8-yl)sulfanyl]methyl}benzonitrile | 3 |
| 5AD | 5'-DEOXYADENOSINE | 2 |
| 5RZ | 2-azanyl-8-[2-(4-bromophenyl)-2-oxidanylidene-ethyl]sulfanyl-1,9-dihydropurin-6-one | 2 |
| B55 | 2-amino-8-sulfanyl-1,9-dihydro-6H-purin-6-one | 2 |
| GSY | 7-(2-HYDROXYETHYL)-8-MERCAPTOGUANINE | 2 |